Schedule 13D ownership disclosure

ImmunityBio Inc

Security class unavailable · CUSIP: 45256X103

Event date: 2023-12-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
39.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-24-001705
Form type
SC 13D/A
Filer
Cambridge Equities, LP
CIK
CIK 1629222
Filed
Jan 04, 2024
Reporting period
Dec 29, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub